Revaia

About Revaia

Revaia is a Paris-based growth equity investment fund with €600 million of assets under management, founded in 2018 and focusing on partnering with mission-driven entrepreneurs to support European technology companies from growth stage to IPO or buyout exit. The growth equity mandate distinguishes Revaia from early-stage VC peers, with the firm investing in profitable scaling tech companies with proven business models.

Investment thesis

Revaia targets European technology companies at growth equity stage with €5 million-plus annual revenue and proven business models, deploying equity tickets typically ranging from €10 million to €40 million per transaction. Sector focus spans HealthTech, enterprise software, fintech and selectively other European tech verticals. The mission-driven entrepreneurship filter aligns Revaia's investment criteria with ESG-conscious limited partners seeking impact-aware growth equity exposure.

Recent activity

Recent realised exits include Hublo (healthcare, 2025), reflecting selective distribution activity across the European tech growth portfolio. The platform tracks 2 funds, 20 active portfolio companies and 1 realised exit across the growth equity programme.

Frequently asked questions

What investment strategy does Revaia focus on?

Revaia focuses on Growth strategies in the private equity space.

How many portfolio companies does Revaia have?

Revaia has 21 active portfolio companies and 2 completed exits and 2 funds tracked on GP Intel.

Where is Revaia headquartered?

Revaia is headquartered in PARIS, France.

What is Revaia's assets under management?

Revaia manages approximately €600M in assets under management.

When was Revaia founded?

Revaia was founded in 2018.

What sectors does Revaia invest in?

Revaia invests across TMT, Software, Consumer, Financials, Business Services.

What are Revaia's recent exits?

Recent realized exits by Revaia include: Hublo (2025) to Five Arrows (Rothschild and Co); GoHenry (2023) to Acorns.